Skip to content


Vaccines Bioprocess Development & Commercialization Workshop

This two-day workshop will explore the critical issues at the various stages of vaccine development. International experts with over 10 years’ experience in their field will lead delegates in developing their understanding in the research, operational, and regulatory challenges of the vaccine market.

 This workshop is suitable for:

  • scientists new to the vaccines sector (recent graduates / research scientists)
  • scientists and technical managers looking to broaden their knowledge in various vaccine technologies and platforms
  • project managers, funders and policy-makers wanting to gain an understanding in vaccines


This year’s course will feature presentations from:

Alison Armstrong, Merck Group
Paul W. Barone, MIT
Dan Barouch, Harvard
Barry Buckland, University College London
Kimberly Duffy, Merck
Mark Feinberg, IAVI
Stefanie Frank, University College London
Adrian Hill, Oxford
Steve Kolodziej, Pfizer
J. Christopher Love, MIT
Peter Marks, USFDA
Tarit Mukhopadhyay, Merck
Derek O’Hagan, GSK
Julia O’Neill, Moderna
Don Parsons, Moderna
Tania Pereira, Univercells
David Robinson, Gates Foundation
Stacy Springs, MIT
Dave Sullivan, Pfizer
Raghavan Venkat, AstraZeneca


The event will run in a hybrid format that is comprised of two-days of live, in-person sessions and a library of on-demand, previously recorded lectures.  The live 2021 Vaccines Workshop will take place at the MIT Samberg Conference Center.

Note: due to the ever-changing nature of the pandemic, this event may transition to fully virtual as circumstances require.


Registration for the 2021 Vaccines Workshop is now open!

Click HERE to register.
Contact Karyn Glemaud-Anis with any questions or concerns about the registration process.

  • Date

    December 13, 2021 8:00 am – December 14, 2021 5:00 pm
  • Location

    MIT Samberg Confrence Center
    50 Memorial Drive, Cambridge, MA, 02142, United States

  • Cost